
Optura is an AI orchestration company committed to transforming healthcare by unlocking the full potential of artificial intelligence. Guided by a team of proven experts from the healthcare and technology sectors, we specialize in delivering value-driven AI solutions that scale enterprise productivity and deliver rapid, measurable ROI through our cutting-edge AI EOS (Enterprise Operating System) platform. Our mission is clear : to empower healthcare organizations to confidently embrace AI and help healthcare break free from its 17%+ pull on the GDP. At Optura, we’re not just enabling AI—we’re shaping a future where technology becomes a catalyst for meaningful healthcare transformation.

Optura is an AI orchestration company committed to transforming healthcare by unlocking the full potential of artificial intelligence. Guided by a team of proven experts from the healthcare and technology sectors, we specialize in delivering value-driven AI solutions that scale enterprise productivity and deliver rapid, measurable ROI through our cutting-edge AI EOS (Enterprise Operating System) platform. Our mission is clear : to empower healthcare organizations to confidently embrace AI and help healthcare break free from its 17%+ pull on the GDP. At Optura, we’re not just enabling AI—we’re shaping a future where technology becomes a catalyst for meaningful healthcare transformation.
Sector: Healthcare AI / enterprise AI orchestration
HQ: Nashville, Tennessee
Founders / leadership: Andy Fanning (Co‑Founder, CEO); Michael Hollis (Co‑Founder, President)
Notable funding: $6.5M seed (May 2025) with participation from Susa Ventures and Matrix Partners
Employees (approx.): 38
| Company |
|---|
Low adoption and difficulty measuring ROI for AI in healthcare; need to prioritize, govern, and scale AI initiatives across enterprise operations.
2024
Software Development
$6.5M
Described as a strategic investment to expand healthcare-specific AI agents
“Company backed by institutional VC (Susa Ventures, Matrix Partners) and a later strategic investor (HC9 Ventures)”